BioTheraVision
Who is BioTheraVision
BioTheraVision, Inc. (BTV) is a privately held, pre-clinical stage pharmaceutical company focused on developing ophthalmic therapeutics. Our approach is to repurpose known molecules through unleashing hidden potentials to treat ocular diseases where practitioners and patients are still vastly frustrated with current treatments. Our lead product candidates are BTV100 for treating ocular dry eye disease and BT300 for treating post-ocular surgery inflammation. BioTheraVision is based in Chicago, Illinois and is led by a team of pharmaceutical experts who have years of ocular drug development and drug delivery experience. BTV currently has 6 patents pending in the U.S. for its portfolio of projects.Read More
Headquarters:
Employees:
Revenue:
BioTheraVision Inc
Biotheravision LLC
BioTheraVision
BioTheraVision's Tech Stack
Frequently Asked Questions regarding BioTheraVision
Where are BioTheraVision’s headquarters?
BioTheraVision’s headquarters are in 420 N Wabash Ave, Ste 539, Chicago, Illinois, 60611, United States
What is BioTheraVision’s official website?
BioTheraVision’s official website is biotheravision.com
What is BioTheraVision’s Revenue?
BioTheraVision’s revenue is $6 Million
What is BioTheraVision’s SIC code?
BioTheraVision’s SIC: 2834,283
What is BioTheraVision’s NAICS code?
BioTheraVision’s NAICS: 32541,325
How many employees are working in BioTheraVision?
BioTheraVision has 30 employees
What is BioTheraVision’s industry?
BioTheraVision is in the industry of: Drug Manufacturing & Research, Pharmaceuticals, Healthcare
What is BioTheraVision's tech stack?
The technologies that are used by BioTheraVision are: GoDaddy DNS, GoDaddy Web Hosting, Google Font API, Font Awesome
Who is BioTheraVision's CEO?
BioTheraVision's CEO is Andreas Bodmeier
Rate Andreas Bodmeier as a Chief Executive Officer & President
4.4/5 on G2 Crowd
Test Drive ZoomInfo's Directories
Browse Directories
